Bain Capital Life Sciences Investors, LLC Q4 2017 Filing
Filed February 14, 2018
Portfolio Value
$152.4B
Holdings
3
Report Date
Q4 2017
Filing Type
13F-HR
All Holdings (3 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —DICERNA PHARMACEUTICALS INC | 8,930,237 | $80.6B | 52.91% | |
| 2 | IFRXINFLARX NV | 1,876,413 | $39.3B | 25.79% | |
| 3 | —MARINUS PHARMACEUTICALS INC | 3,977,453 | $32.5B | 21.30% |